Workflow
总市值
icon
Search documents
三博脑科收盘上涨5.50%,滚动市盈率107.94倍,总市值118.63亿元
Sou Hu Cai Jing· 2025-08-08 10:17
Group 1 - The core viewpoint of the news is that Sanbo Brain Science has seen a significant increase in its stock price, reaching 57.59 yuan, which is a 5.50% rise, while its rolling PE ratio has dropped to 107.94, marking a new low in 306 days [1] - The total market capitalization of Sanbo Brain Science is 11.863 billion yuan, and it ranks 38th in the medical services industry based on PE ratio, which has an average of 46.98 and a median of 58.58 [1][2] - In terms of capital flow, on August 8, Sanbo Brain Science experienced a net outflow of 328.60 million yuan, with a total outflow of 249.01 million yuan over the past five days [1] Group 2 - The main business of Sanbo Brain Science is clinical medical services, with key products including medical services, pharmaceuticals, and supply chain operations [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 393 million yuan, representing a year-on-year increase of 16.78%, and a net profit of 38.31 million yuan, up 14.56%, with a gross profit margin of 26.44% [1]
北京人力收盘下跌2.06%,滚动市盈率9.87倍,总市值115.66亿元
Sou Hu Cai Jing· 2025-08-07 11:01
Company Overview - Beijing Human Capital Group Co., Ltd. specializes in comprehensive human resource services, including business outsourcing, personnel management, compensation and benefits services, recruitment, and flexible employment services [1] - The company has received multiple accolades, including being recognized as a "National Employment Advanced Enterprise" and a "5A Human Resource Service Institution" by the Beijing Human Resources and Social Security Bureau [1] Financial Performance - As of the first quarter of 2025, the company reported a revenue of 10.837 billion yuan, representing a year-on-year increase of 2.72% [1] - The net profit for the same period was 591 million yuan, showing a significant year-on-year growth of 180.41% [1] - The sales gross margin stood at 5.63% [1] Market Position - The company's stock closed at 20.43 yuan, down 2.06%, with a rolling price-to-earnings (PE) ratio of 9.87 times [1] - The total market capitalization is 11.566 billion yuan [1] - In comparison to the industry, the average PE ratio for the professional services sector is 71.91 times, with a median of 43.52 times, placing Beijing Human Capital in the 8th position within its industry [2] Institutional Holdings - As of the first quarter of 2025, 14 institutions hold shares in Beijing Human Capital, all of which are funds, with a total holding of 35.2486 million shares valued at 680 million yuan [1]
迪阿股份收盘上涨3.13%,滚动市盈率264.98倍,总市值117.36亿元
Jin Rong Jie· 2025-08-07 10:29
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Diya Co., which has a current stock price of 29.34 yuan, reflecting a 3.13% increase, with a rolling PE ratio of 264.98, marking a new low in 19 days [1] - Diya Co. operates in the jewelry sector, which has an average industry PE ratio of 59.17 and a median of 40.27, placing Diya Co. at the 15th position in the industry ranking [1][2] - As of the first quarter of 2025, two institutions hold shares in Diya Co., with a total of 150.98 million shares valued at 0.45 million yuan [1] Group 2 - The main business of Diya Co. includes brand operation, customized sales, and research and design of jewelry, with key products being engagement rings, wedding bands, anniversary gifts, and wedding gold [1] - The latest financial results for the first quarter of 2025 show that Diya Co. achieved a revenue of 408 million yuan, a year-on-year decrease of 4.40%, and a net profit of 20.72 million yuan, down 29.66%, with a gross margin of 63.52% [1] - The PE ratios for Diya Co. are significantly higher than the industry averages, with a TTM PE of 264.98 and a static PE of 221.32, while the industry average PE is 59.17 [2]
英科医疗收盘上涨1.53%,滚动市盈率15.92倍,总市值251.53亿元
Sou Hu Cai Jing· 2025-08-07 09:57
8月7日,英科医疗今日收盘38.42元,上涨1.53%,滚动市盈率PE(当前股价与前四季度每股收益总和的 比值)达到15.92倍,总市值251.53亿元。 最新一期业绩显示,2025年一季报,公司实现营业收入24.94亿元,同比13.20%;净利润3.53亿元,同 比48.08%,销售毛利率24.16%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)2英科医疗15.9217.161.42251.53亿行业平均 54.7951.294.80116.92亿行业中值37.8638.002.7755.22亿1九安医疗11.1511.280.88188.19亿3新华医疗 16.1314.951.32103.38亿4振德医疗16.1915.261.0358.78亿5山东药玻16.2416.291.87153.63亿6奥美医疗 16.7216.391.7260.41亿7康德莱17.6917.711.4738.13亿8维力医疗17.7518.972.2341.62亿9九强生物 17.8316.582.1888.30亿10奥泰生物18.5619.571.5059.18亿11鱼跃医疗20.0419.652.71354. ...
农行登顶A股“市值之王”背后:大行AH股分布比例差异大
第一财经· 2025-08-07 09:55
Core Viewpoint - The article highlights the significant rise of Agricultural Bank of China (ABC) as it surpasses Industrial and Commercial Bank of China (ICBC) to become the largest market capitalization bank in A-shares, marking a notable shift in the banking sector dynamics [2][5][6]. Market Performance - On August 6, A-shares recorded a three-day rise with over 3,300 stocks increasing in value, while the margin trading balance exceeded 2 trillion yuan for the first time in 10 years [2]. - As of the close on August 6, ABC's A-share market capitalization reached 2.11 trillion yuan, surpassing ICBC's 2.09 trillion yuan, a historic first [2][4]. - The top three A-share market capitalizations are now ABC, ICBC, and Kweichow Moutai, compared to the beginning of the year when the order was Kweichow Moutai, ICBC, and ABC [2]. Stock Performance - ABC's A-share price increased by 29.54% year-to-date, ranking third among 42 listed banks, while ICBC's price rose by 16.85% [7][8]. - Over the past year, ABC's stock has surged by approximately 49%, leading among major banks, with significant increases of 106% and 172% over the past two and three years, respectively [8]. Market Capitalization Changes - The total market capitalization of the banking sector in A-shares has surpassed 10 trillion yuan for the first time in the first half of the year, with ABC's market capitalization increasing by 4.086 billion yuan since the beginning of the year [6][9]. - The total market capitalization of state-owned banks has increased by approximately 1.6 trillion yuan since the beginning of the year, with ABC and China Construction Bank showing the largest increases [15]. Financial Performance - In Q1, ABC reported a revenue growth of 2.56%, while other major banks experienced negative growth, indicating its strong performance amidst a challenging environment [9]. - The asset scale of the six major banks has exceeded 200 trillion yuan, with ABC's non-performing loan ratio decreasing by 0.02 percentage points [10]. A-H Share Distribution - The article discusses the distribution of A and H shares among major banks, noting that ABC has the highest proportion of A shares at approximately 91%, while CCB has the lowest at about 8% [12][14]. - The A-share market capitalization of ABC is significantly influenced by its high A-share proportion compared to other banks, which have a larger portion of their shares listed in Hong Kong [14]. Future Outlook - Analysts suggest that the sustainability of the banking sector's performance will depend on several indicators, including the banks reaching a price-to-book ratio of 1 and the allocation of public funds to banks [15].
洛阳钼业收盘上涨1.39%,滚动市盈率13.21倍,总市值2034.60亿元
Jin Rong Jie· 2025-08-06 11:20
截至2025年一季报,共有212家机构持仓洛阳钼业,其中基金212家,合计持股数42257.90万股,持股市 值35.58亿元。 洛阳栾川钼业集团股份有限公司的主营业务是基本金属、稀有金属的采、选、冶等矿山采掘及加工业务 和矿产贸易业务。公司的主要产品是矿山采掘及加工、钼、钨、铜(不含NPM)、钴、铌、磷、铜金 (NPM)、矿产贸易、矿物金属贸易、精炼金属贸易。 8月6日,洛阳钼业今日收盘9.51元,上涨1.39%,滚动市盈率PE(当前股价与前四季度每股收益总和的 比值)达到13.21倍,创1793天以来新低,总市值2034.60亿元。 从行业市盈率排名来看,公司所处的小金属行业市盈率平均65.31倍,行业中值61.61倍,洛阳钼业排名 第5位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)1洛阳钼业13.2115.042.762034.60亿行业平均 65.3174.704.47233.81亿行业中值61.6162.483.94131.56亿2金钼股份14.6314.012.36417.85亿3锡业股份 18.5120.731.58299.37亿4贵研铂业20.0620.361.62118.00亿 ...
尚荣医疗收盘下跌2.29%,滚动市盈率145.18倍,总市值32.47亿元
Sou Hu Cai Jing· 2025-08-06 09:08
Core Viewpoint - 尚荣医疗's stock closed at 3.84 yuan, down 2.29%, with a rolling PE ratio of 145.18 times, and a total market value of 3.247 billion yuan [1] Company Overview - Shenzhen 尚荣医疗股份有限公司 specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is one of the earliest to introduce clean technology into hospital operating rooms in China [1] - 尚荣医疗 has received numerous honors, including national key new product recognition and awards from the Shenzhen municipal government for technological progress [1] - The company holds over 180 patents, which are a key driver of its continuous development [1] Financial Performance - In Q1 2025, the company reported operating revenue of 280 million yuan, a year-on-year increase of 30% [2] - Net profit for the same period was 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The sales gross margin stood at 15.27% [2] Industry Comparison - The average PE ratio for the medical device industry is 53.93 times, with a median of 37.81 times, placing 尚荣医疗 at 111th in the industry ranking [1][2] - The company's PE (TTM) is significantly higher than the industry average, indicating potential overvaluation [2]
伟思医疗收盘上涨4.64%,滚动市盈率40.91倍,总市值46.41亿元
Sou Hu Cai Jing· 2025-08-05 11:35
Company Overview - Weisi Medical's closing price on August 5 was 48.46 yuan, an increase of 4.64%, with a rolling PE ratio of 40.91, marking a new low in 63 days, and a total market capitalization of 4.641 billion yuan [1] - The main business of Nanjing Weisi Medical Technology Co., Ltd. includes the research, production, and sales of medical devices, with key products in magnetic stimulation, electrical stimulation, electrophysiology, consumables and accessories, and laser radiofrequency [1] Financial Performance - For the first quarter of 2025, Weisi Medical reported operating revenue of 95.9127 million yuan, a year-on-year increase of 9.40%, and a net profit of 33.2201 million yuan, a year-on-year increase of 52.71%, with a gross profit margin of 66.65% [1] Industry Comparison - The average PE ratio for the medical device industry is 54.24, with a median of 37.92, placing Weisi Medical at the 81st position in the industry ranking [1] - The industry average market capitalization is 11.546 billion yuan, while Weisi Medical's market capitalization is significantly lower at 4.641 billion yuan [2]
中国石化收盘上涨1.06%,滚动市盈率15.30倍,总市值6923.10亿元
Sou Hu Cai Jing· 2025-08-05 10:18
序号股票简称PE(TTM)PE(静)市净率总市值(元)5中国石化15.3013.760.836923.10亿行业平均 12.8311.541.201833.77亿行业中值30.4834.631.6561.75亿1中国海油9.188.971.5812372.05亿2中国石油 9.499.551.0015721.50亿3广汇能源12.2311.771.26348.36亿4*ST新潮13.4413.301.18270.66亿6洲际油气 23.0820.511.1599.99亿7泰山石油24.6933.253.0233.03亿8东华能源36.2636.001.44159.82亿9康普顿 45.3655.432.5830.29亿10广聚能源61.4966.332.2864.31亿11和顺石油87.5997.681.7328.59亿12岳阳兴长 107.3593.762.7259.19亿 来源:金融界 8月5日,中国石化今日收盘5.71元,上涨1.06%,滚动市盈率PE(当前股价与前四季度每股收益总和的 比值)达到15.30倍,总市值6923.10亿元。 中国石油化工股份有限公司的主营业务为石油及天然气和化工业务。石油及 ...
神开股份收盘上涨3.10%,滚动市盈率67.08倍,总市值36.32亿元
Sou Hu Cai Jing· 2025-08-05 08:45
Group 1 - The core viewpoint of the articles highlights the performance and valuation of ShenKai Co., which closed at 9.98 yuan with a 3.10% increase, resulting in a rolling PE ratio of 67.08 times and a total market value of 3.632 billion yuan [1][2] - ShenKai Co. operates in the specialized equipment industry, which has an average PE ratio of 72.72 times and a median of 57.38 times, placing ShenKai at the 176th position in the industry ranking [1][2] - As of April 30, 2025, the number of shareholders in ShenKai Co. is 60,721, a decrease of 13,650 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Group 2 - The main business of ShenKai Co. includes research, development, manufacturing, and sales of equipment in the oil exploration, drilling, and refining sectors, with key products such as oil drilling equipment, logging equipment, and oil analysis instruments [1] - In the latest quarterly report for Q1 2025, ShenKai Co. reported an operating revenue of 202 million yuan, a year-on-year increase of 41.78%, and a net profit of 18.46 million yuan, reflecting a significant year-on-year growth of 434.81%, with a gross profit margin of 33.79% [1]